Dr. Herbert Ho Ping Kong – 2016 FCMS Achievement Award in Education

Dr. Herbert Ho Ping Kong was selected as the inaugural recipient of the FCMS Achievement Award in Education in 2016, recognizing his exceptional contributions to clinical teaching, general internal medicine, and compassionate patient care. A Jamaican Chinese physician whose career brought him from the Caribbean to Montreal and Toronto, he helped shape generations of physicians through an approach that brought scientific knowledge, careful observation, and human understanding together. His award recognized a career devoted to improving both how medicine is taught and how it is practised.

Born in Jamaica, Dr. Ho Ping Kong graduated with honours in medicine from the University College of the West Indies in 1965 and completed his Ph.D. at the University of the West Indies in 1970. His postgraduate training included a Commonwealth Medical Scholarship in the United Kingdom. He subsequently developed his academic career at McGill University, where he became the founding director of the Division of General Internal Medicine at the Royal Victoria Hospital in 1981. He joined the University of Toronto in 1984 and became Professor of Medicine in 1990.

Across these institutions, Dr. Ho Ping Kong helped establish general internal medicine as an essential academic discipline. His leadership included directing residency training in medicine at the Toronto Hospital and serving as Chief of Medicine at Toronto Western Hospital. In 2004, he became the inaugural holder of the Gladstone and Maisie Chang Chair in Teaching of Internal Medicine at the University of Toronto and University Health Network. These appointments provided opportunities to strengthen clinical education from undergraduate teaching through specialist training.

At the bedside, his teaching made a lasting impression. Known to colleagues and learners as “HPK,” he used questions, riddles, and guided discovery to help trainees develop their own diagnostic reasoning. His 2016 nomination described a physician with remarkable observational skills who remained approachable and humble, consistently emphasizing compassionate care. By that time, his teaching had reached thousands of medical students and hundreds of internal medicine residents.

In 2008, he co-founded the Centre of Excellence in Education and Practice with Dr. Rodrigo Cavalcanti at Toronto Western Hospital. Subsequently named in his honour, the centre supported innovative clinical education, advanced training, and scholarly careers in general internal medicine. Its work extended his commitment to physical diagnosis, clinical reasoning, and the development of physicians who would themselves become effective teachers.

His educational influence also reached the Caribbean through his support for physicians undertaking subspecialty training in Toronto. In 2014, he shared his philosophy with a wider readership in The Art of Medicine: Healing and the Limits of Technology, written with Michael Posner.

His honours included a 3M National Teaching Fellowship in 1999, the Canadian Society of Internal Medicine’s Osler Award in 2003, and Jamaica’s Order of Distinction in 2015. Through clinical example, mentorship, and institution building, Dr. Ho Ping Kong embodied the excellence, integrity, and compassion celebrated by FCMS. His legacy resides in the physicians he taught and the patients whose care they carry forward.

 

Dr. Yuet Wai Kan – 2016 FCMS Achievement Award in Research

Dr. Yuet Wai Kan was selected as the inaugural recipient of the FCMS Achievement Award in Research in 2016, recognizing pioneering contributions that helped bring molecular genetics into clinical medicine. His investigations of inherited blood disorders advanced the use of DNA analysis in diagnosis and opened new directions for understanding human disease. Through a career connecting laboratory discovery with clinical questions, he demonstrated how fundamental research could change the possibilities available to patients and families.

Born in Hong Kong, Dr. Kan graduated in medicine from the University of Hong Kong in 1958. He pursued further clinical and research training in North America, developing a particular interest in hematology. He joined the faculty of the University of California, San Francisco, in 1972 and received a Doctor of Science degree from the University of Hong Kong in 1980. His academic career at UCSF included the Louis K. Diamond Professorship of Hematology and leadership in molecular medicine and diagnostics.

Central to his research were sickle cell disease and thalassemia, inherited disorders affecting hemoglobin. His work helped establish methods for identifying these conditions through DNA analysis, including prenatal diagnosis. These advances connected the molecular basis of disease with practical diagnostic tools, helping move genetics from the research laboratory into clinical application.

One of Dr. Kan’s most influential contributions was the discovery of a DNA sequence polymorphism associated with the sickle cell gene. His work helped demonstrate how inherited variations in DNA could serve as markers for tracing disease genes. The significance extended beyond hematology: these approaches contributed to the development of genetic analysis across a much wider range of human disorders. His discoveries became part of the foundation on which subsequent work in molecular diagnosis and human genetics could build.

His research held particular relevance for FCMS through its attention to thalassemia and the needs of populations affected by inherited blood disorders, including Chinese and other Asian communities. By the time of his 2016 nomination, his laboratory was also investigating gene and cell therapy approaches. The nomination documented research involving induced pluripotent stem cells and reported more than 260 scientific publications, reflecting sustained contributions across several decades.

Dr. Kan also served the wider scientific community through professional leadership, including the presidency of the American Society of Hematology and service with the Shaw Prize. His international recognition included election to the Royal Society and the United States National Academy of Sciences. Major honours included the Gairdner International Award in 1984, the Albert Lasker Clinical Medical Research Award in 1991, and the Shaw Prize in Life Science and Medicine in 2004.

The FCMS Achievement Award recognized both the originality of his discoveries and their enduring medical significance. By connecting questions arising from inherited blood diseases with powerful new methods of genetic investigation, Dr. Kan advanced knowledge with consequences far beyond his own specialty. His career exemplified the FCMS commitment to scientific excellence and to research that improves human health.